Pancrelipase

Pancrelipase is a mixture of digestive enzymes (lipase, protease, and amylase) derived from pig pancreases. These enzymes help break down and digest fats, starches, and proteins in food, ensuring proper nutrient absorption in individuals with impaired pancreatic function.

Dosage by Body Weight

Dosage must be individualized based on clinical symptoms, degree of steatorrhea, and dietary fat content. Take immediately before or during meals and snacks with sufficient liquid. Do not crush, chew, or hold the capsules or tablet contents in the mouth, as this can cause mucosal irritation. For infants, capsule contents may be sprinkled on acidic soft food (like applesauce) and given immediately.

  1. Body Weight
    Below 5 kg
    Dose
    2,000 to 4,000 lipase units
    Frequency
    With each feeding (breast milk or formula)
    Tracking Notes
    Administer immediately before feeding. Do not mix capsule contents directly into formula or breast milk.
  2. Body Weight
    5-7 kg
    Dose
    5,000 to 7,000 lipase units
    Frequency
    With each meal
    Tracking Notes
    Dosed at approximately 1,000 lipase units/kg/meal. Use half-dose (2,500 to 3,500 units) for snacks.
  3. Body Weight
    8-10 kg
    Dose
    8,000 to 10,000 lipase units
    Frequency
    With each meal
    Tracking Notes
    Dosed at approximately 1,000 lipase units/kg/meal. Use half-dose (4,000 to 5,000 units) for snacks.
  4. Body Weight
    11-15 kg
    Dose
    11,000 to 15,000 lipase units
    Frequency
    With each meal
    Tracking Notes
    Dosed at approximately 1,000 lipase units/kg/meal. Use half-dose (5,500 to 7,500 units) for snacks.
  5. Body Weight
    16-20 kg
    Dose
    16,000 to 20,000 lipase units
    Frequency
    With each meal
    Tracking Notes
    Dosed at approximately 1,000 lipase units/kg/meal. Use half-dose (8,000 to 10,000 units) for snacks. Maximum daily dose should not exceed 10,000 lipase units/kg/day.

Formulation

Delayed-Release CapsuleTablet

Purpose

Pancreatic enzyme replacement therapy (PERT) used to treat malabsorption and exocrine pancreatic insufficiency (EPI) caused by cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions where the pancreas cannot produce enough digestive enzymes.

Generic Name

Pancrelipase

Branded Drug Names

Pancrelipase is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.